News came later, chart already shown sign of bullishness. Bou | Vibhor Varshney

News came later, chart already shown sign of bullishness. Bought at 1055, now at 1320 Simply 25% #PharmEasy in talks to buy Thyrocare in deal worth around Rs 7,000 crore. The deal is likely to announced soon given the IPO timelines of it's parent company…